Cleared Traditional

K820820 - CARDIO REVUE CENTER

K820820 is an FDA 510(k) clearance for CARDIO REVUE CENTER, manufactured by Diasonics, Inc.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 36-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1982
Decision
36d
Days
Class 2
Risk

K820820 is an FDA 510(k) clearance for the CARDIO REVUE CENTER. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Diasonics, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 29, 1982 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K820820

510(k) Number K820820 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 1982
Decision Date April 29, 1982
Days to Decision 36 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 125d · This submission: 36d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 176
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K820820.
MODEL 78554A DATA MGMT. PLUG-IN MODULE
K822877 · Hewlett-Packard Co. · Oct 1982
STAT-SCAN
K822093 · Survival Technology, Inc. · Sep 1982
CARDIAC CATHERIZATION LAB MICROPROCESS
K820194 · Compu-Cath Corp. · May 1982
VASCULAB SPECTRUM ANALYZER #SP25
K820898 · Medasonics, Inc. · Apr 1982
DISPOSABLE PLASTIC SYRINGE W/NEEDLE
K813223 · Sam Joo Industrial Co., Ltd. · Apr 1982
CARDIOINTEGRAM
K812971 · Ocg Technology, Inc. · Dec 1981